Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited
Summary
Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited was set up on Monday the 20th of April 2015. Their current partial address is Dublin 2, and the company status is Dissolved with the company closing on Thursday the 26th of June 2025. The company's current directors have been the director of 1 other Irish company between them; 1 of which is now closed. Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited has 1 shareholder. This Irish company shares its Eircode with at least 426 other companies.
Credit Score
- Latest Credit Movement:
- Date of Last Movement:26/03/2025
- Latest Accounts Filed:25/11/2021
- Report Based On Accounts:31/12/2020
- Next Set of Accounts Due:30/09/2022
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited
- Time in Business:10 Years
- Company Number:560724
- Company Size:Micro Company
- Current Status:DISSOLVED
- Principal Activity: ? [65.XX] Financial Intermediation, Except Insurance and Pension Funding
- May Trade As:Glaxosmithkline Consumer Healthcare Investments Ireland No 3 Ltd
- Add My Company Details
- Registered Address:Bdo,
Beaux Lane House,
Mercer Street Lower,
Dublin 2
D02 DH60
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Documents
| Document | Pages | Effective | Received | Buy |
|---|---|---|---|---|
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 6 | 06/03/2025 | 25/03/2025 | |
| Form E6: Return of final winding up meeting | 3 | 06/03/2025 | 25/03/2025 | |
| Form E5: Liquidator`s Final Statement of Accounts | 7 | 06/03/2025 | 25/03/2025 | |
| Form E3: Liquidator`s Accounts of Acts & Dealings | 3 | 21/12/2024 | 07/02/2025 | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 10 | 21/12/2024 | 08/01/2025 | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 6 | 21/06/2024 | 25/06/2024 | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 6 | 21/12/2023 | 04/01/2024 | |
| Form E3: Liquidator`s Accounts of Acts & Dealings | 3 | 21/12/2023 | 04/01/2024 | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 6 | 21/06/2023 | 20/10/2023 | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 5 | 21/12/2022 | 04/01/2023 | |
| Form E3: Liquidator`s Accounts of Acts & Dealings | 3 | 21/12/2022 | 04/01/2023 | |
| E1-SAP Declaration of Solvency Summary App Procd | 4 | 13/12/2021 | 23/12/2021 | |
| Form E2: Notice of Appointment of Liquidator(s) | 1 | 22/12/2021 | 23/12/2021 | |
| Form B1C - Annual Return General | 4 | 30/09/2021 | 25/11/2021 | |
| Constitution | 8 | 18/11/2016 | 29/11/2016 | |
| Migrated Certificate | 2 | 20/04/2015 | 14/04/2015 |